Liquidity Services Announces First Quarter Fiscal Year 2026 Earnings Conference Call

Liquidity Services Announces First Quarter Fiscal Year 2026 Earnings Conference Call GlobeNewswire January 06, 2026 BETHESDA, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ:LQDT), the leading global provider of e-commerce marketplaces and software solutions powering the circular economy, today announced that it expects to report its first quarter fiscal year 2026 results prior […]

Sound Group Launches SoundSphereAI, a Voice AI Technology Showcase Platform

(NASDAQ:SOGP), SINGAPORE, Jan. 06, 2026 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global AI-powered audio company, today announced the official launch of SoundSphereAI, a voice AI technology showcase and experience platform designed for a global audience. The platform presents selected voice AI technologies and R&D achievements across automatic

Sound Group Launches SoundSphereAI, a Voice AI Technology Showcase Platform

Sound Group Launches SoundSphereAI, a Voice AI Technology Showcase Platform GlobeNewswire January 06, 2026 SINGAPORE, Jan. 06, 2026 (GLOBE NEWSWIRE) — Sound Group Inc. (“Sound Group” or the “Company”) (NASDAQ: SOGP), a global AI-powered audio company, today announced the official launch of SoundSphereAI, a voice AI technology showcase and experience platform designed for a global

Phase 6 Goes Live: Blazpay AI Crypto Presale Opens at $0.0155 With $2.23M Raised

PANAMA CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) — Blazpay's AI crypto presale continues its explosive rise as the project officially crosses $2.23M raised while entering Phase 6. With 252.25M tokens sold and nearly 97% of all presale tokens completed, Blazpay is rapidly positioning itself among the best crypto presales and one of the most exciting

Phase 6 Goes Live: Blazpay AI Crypto Presale Opens at $0.0155 With $2.23M Raised

Phase 6 Goes Live: Blazpay AI Crypto Presale Opens at $0.0155 With $2.23M Raised GlobeNewswire January 06, 2026 PANAMA CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) — Blazpay's AI crypto presale continues its explosive rise as the project officially crosses $2.23M raised while entering Phase 6. With 252.25M tokens sold and nearly 97% of all presale

Radisson annonce de nouveaux resultats a hautes teneurs et prolonge davantage la nouvelle mineralisation sous l'ancienne mine d'or O'Brien

Rouyn-Noranda, Quebec–(Newsfile Corp. – 6 janvier 2026) – Ressources minières Inc. (TSXV: RDS) (OTCQX: RMRDF) (« Radisson » ou la « Société ») est heureuse d’annoncer les résultats d’analyse de 6 nouveaux sondages réalisés sur son projet aurifère O’Brien, détenu à 100 % (« O’Brien » ou le « Projet »), situé dans la région

Radisson Announces Additional High-Grade Drill Results and Further Extends New Mineralization Beneath the Historic O'Brien Gold Mine

Rouyn-Noranda, Quebec–(Newsfile Corp. – January 6, 2026) – Radisson Mining Resources Inc. (TSXV: RDS) (OTCQX: RMRDF) (“Radisson” or the “Company”) is pleased to announce assay results from six new drill holes completed at its 100%-owned O’Brien Gold Project (“O’Brien” or the “Project“) located in the Abitibi region of Québec. The six holes are the latest

Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that it has submitted its NDA to the FDA for approval of its novel therapy for the treatment of knee osteoarthritis (“OA”). Biosplice's drug candidate, lorecivivint (“LOR”),

ThinkLabs AI achieves results in AI-powered grid analytics

NEW YORK, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) — ThinkLabs AI, a company specializing in AI-driven grid solutions, today announced results in collaboration with Southern California Edison (SCE) using physics-informed AI digital twins to model and analyze electric distribution and sub-transmission networks. This technology enables AI-powered automation of grid energization requests, accelerating connections and enhancing

Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis

Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis LOR is the first drug candidate with disease-modifying potential for osteoarthritis submitted for approval, demonstrating statistically and clinically significant improvements in pain, function and medial joint space width when compared with placebo, along with very

Scroll to Top